HTS: Publications by James W. Jefferson, MD

Jefferson JW: Psychophytopharmacology: a botanical update. American Society of Clinical Psychopharmacology Progress Notes 10(1):5-7, Winter-Spring 2000.

Jefferson JW: Patient compliance in depression. The American Journal of Managed Care 6(2):31-37, 2000.

Kobak KA, Mundt JC, Greist JH, Katzelnick DJ, Jefferson JW: Computer assessment of depression: automating the Hamilton Depression Rating Scale. Drug Information Journal 34(1):145-156, 2000. Abstract

Chaudron LH, Jefferson JW: Mood stabilizers during breastfeeding: a review. J Clin Psychiatry 61(2):79-90, 2000.

Jefferson JW: Benzodiazepines and anticonvulsants for social phobia (social anxiety disorder). J Clin Psychiatry 62(suppl 1):50-53, 2001.

Jefferson JW: Social anxiety disorder: more than just a little shyness. Primary Care Companion Journal of Clinical Psychiatry 3(1):4-9, 2001.

Kobak KA, Greist JH, Jefferson JW, Katzelnick DJ: Fluoxetine in social phobia: a double-blind, placebo-controlled pilot study. J Clin Psychopharm 22(3):257-262, 2002

Jefferson JW: Rediscovering the art of lithium therapy. Current Psychiatry 1(12):19-24, 2002

Jefferson JW: Bipolar disorders: a brief guide to diagnosis and treatment. Focus 1(1):7-14, Winter 2003

Jefferson JW: Single-isomer drugs: major advances or magical marketing? International Drug Therapy Newsletter 38(9):65-69, 2003

Pande AC, Feltner DE, Jefferson JW, Davidson JRT, Pollack M, Stein MB, Lydiard RB, Futterer R, Robinson P, Slomkowski M, DuBoff E, Phelps M, Janney CA, Werth JL: Efficacy of the novel anxiolytic pregabalin in social anxiety disorder: a placebo-controlled, multicenter study. Journal of Clinical Psychopharmacology 24(2):141-149, 2004

Piasecki SD, Jefferson JW: Psychiatric complications of deep brain stimulation for Parkinson’s Disease. J Clin Psychiatry 65(6):845-849, 2004
Jefferson JW: Lamotrigine in psychiatry: pharmacology and therapeutics. CNS Spectrums 10(3):224-232, 2005

Jefferson JW: Drug-induced hepatotoxicity. International Drug Therapy Newsletter 40(4):25-30, 2005

Jefferson JW: Old versus new medications: how much should be taught? Academic Psychiatry 29(2):162-166, May-June 2005

Jefferson JW: Finger-stick lithium test. In-office alternative to laboratory-based methods. Current Psychiatry 4(10):111-117, October 2005

Jefferson JW, Pradko JF, Muir Keith T: Bupropion for major depressive disorder: pharmacokinetic and formulation considerations. Clinical Therapeutics 27(11):1685-1695, 2005

Jefferson JW: Lamotrigine in psychiatry: pharmacology and therapeutics. CNS Spectrums 10(3):224-232, 2005

Jefferson JW: Drug-induced hepatotoxicity. International Drug Therapy Newsletter 40(4):25-30, 2005

Jefferson JW: Old versus new medications: how much should be taught? Academic Psychiatry 29(2):162-166, May-June 2005

Jefferson JW: Finger-stick lithium test. In-office alternative to laboratory-based methods. Current Psychiatry 4(10):111-117, October 2005

Jefferson JW, Pradko JF, Muir Keith T: Bupropion for major depressive disorder: pharmacokinetic and formulation considerations. Clinical Therapeutics 27(11):1685-1695, 2005

Jefferson JW and Greist JH: Lithium. In Sadock BJ and Sadock VA (eds.), Comprehensive Textbook of Psychiatry/VIII, vol. 2, Lippincott Williams & Wilkins, Philadelphia, PA, 2005, pp 2839-2851

Jefferson JW: About lamotrigine and its hepatic effects. CNS Spectrums 10(7):522, July, 2005 (letter to the editor)

Jefferson JW: It looks like “bradyphylaxis” to me. J Clin Psychiatry 66(8):1076, August, 2005 (letter to the editor)

Jefferson JW: Discontinuation symptoms: never say never. Current Psychiatry 4(12):3, December, 2005

Jefferson JW, Rush AJ, Nelson JC, VanMeter SA, Krishen A, Hampton KD, Wightman DS, Modell JG: Extended-release bupropion for patients with major depressive disorder presenting with symptoms of reduced energy, pleasure, and interest: findings from a rnadomized, double-blind, placebo-controlled study. J Clin Psychiatry 67(6):865-873, 2006

Moore HK, Mundt JC, Modell JG, Rodrigues HE, DeBrota DJ, Jefferson JW, Greist JH: An examination of 26,168 Hamilton Depression Rating Scale scores administered via interactive voice response across 17 randomized clinical trials. J Clin Psychopharmacol 26(3):321-324, 2006

Katzelnick DJ, Saidi J, Vanelli MR, Jefferson JW, Harper JM, McCrary KE: Time to response in panic disorder in a naturalistic setting: combination therapy with Alprazolam orally disintegrating tablets and serotonin reuptake inhibitors compared to serotonin reuptake inhibitors alone. Psychiatry 3(12):39-49, 2006

Jefferson JW, Greist JH: Rethinking older psychiatric drugs: lithium. Primary Psychiatry 13(12):47-50, 2006

Greist JH, Jefferson JW: Anxiety Disorders. In Beers MH, Porter RS, Jones TV, Kaplan JL and Berkwits M (eds.), The Merck Manual of Diagnosis and Therapy (18 th Edition), Merck Research Laboratories, Whitehouse Station, NJ, 2006, pp 1672-1678. Continuously updated at www.merckmanuals.com

Jefferson JW, Greist JH, Baudhuin MG, Hartley BL, Katzelnick DJ: The Lithium Information Center. In Bauer M, Grof P, Müller-Oerlinghausen B (eds), Lithium Neuropsychiatry – The Comprehensive Guide , Informa UK Ltd, Andover, Hampshire, United Kingdom, 2006, pp 501-504

Jefferson JW: Innovative delivery technologies for psychiatric drugs. International Drug Therapy Newsletter 41(12):91-98, 2006

Jefferson JW, Greist JH: Rethinking older older psychiatric drugs. Primary Psychiatry 13(12)37-38, 2006 (guest editors’ note)

Jefferson JW: Complex chemical concoctions. J Clin Psychiatry 67(2):322-323, February, 2006 (American Society of Clinical Psychopharmacology Corner)

Jefferson JW: Book review on The American Psychiatric Publishing Textbook of Mood Disorders (eds., DJ Stein, DJ Kupfer, AF Schatzberg). Am J Psychiatry 163(10):1844, 2006

Greist JH, Jefferson JW: Obsessive-compulsive disorder. Focus V(3):283-298, Summer 2007

Jefferson JW: Folate for depression: fabulous facilitator or fantastic flop? Psychopharm Review 42(10):75-82, October 2007

Jefferson JW: Antidepressants – The Spectrum Beyond Depression. Current Psychiatry 6(10):334-42, October 2007

Greist JH and Jefferson JW: Obsessive-Compulsive Disorder. In Gabbard GO (ed.), Treatments of Psychiatric Disorders – Fourth Edition, American Psychiatric Publishing, Inc., Washington, D.C., 2007, pp 507-515

Mundt JC, Greist JH, Jefferson JW, Katzelnick DJ, DeBrota DJ, Chappell PB, Modell JG: Is it easier to find what you are looking for if you think you know what it looks like? Journal of Clinical Psychopharmacology 27(2):121-125, 2007 (guest editorial)

Greist J, Mundt J, Jefferson J, Katzelnick D: Comments on “Why Do Clinical Trials Fail? The Problem of Measurement Error in Clinical Trials. Time to Test New Paradigms?” Journal of Clinical Psychopharmacology 27(5):535-537, 2007 (letter to the editors)

Greist JH, Jefferson JW, Katzelnick DJ: Social Anxiety Disorder: A Guide. Information Centers, Madison, WI (booklet), 1997, 2000.

Jefferson JW, Greist JH, Katzelnick DJ: Oxcarbazepine and Bipolar Disorder: A Guide. Information Centers, Madison, WI (booklet), 2002.

Jefferson JW, Endicott J, Greist JH, Katzelnick DJ: Premenstrual Dysphoric Disorder: A Guide. Information Centers, Madison, WI (booklet), 2003

Greist JH, Jefferson JW, Doody RS, Katzelnick DJ: Alzheimer’s Disease: A Guide. Information Centers, Madison, WI (booklet), 2004

Moore DP, Jefferson JW: Handbook of Medical Psychiatry, 2 nd Edition, Elsevier-Mosby, Inc. , Philadelphia, PA, 2004

Moore DP, Jefferson JW: Handbook of Medical Psychiatry, 2 nd Edition, Elsevier-Mosby, Inc., Philadelphia, PA, 2004 (Spanish translation, 2005)

Jefferson JW and Greist JH: Lithium. In Sadock BJ and Sadock VA (eds.), Comprehensive Textbook of Psychiatry/VII, vol. 2, Lippincott Williams & Wilkins, Philadelphia, PA, 2000, pp 2377-2390.

Park LT, Jefferson JW, Greist JH: Obsessive-Compulsive Disorder. In Palmer KJ (ed.), Pharmacotherapy of Anxiety Disorders, Adis International, Auckland, New Zealand, 2000, pp 43-59.

Greist JH and Jefferson JW: Anxiety Disorders. In Goldman HH (ed.), Review of General Psychiatry (5th Edition), McGraw-Hill, New York, 2000, pp 284-300.

Jefferson JW: Lithium. In Dukes MNG and Aronson JK (eds.), Meyler's Side Effects of Drugs, 14th Edition, Elsevier Science B.V., Amsterdam/New York, 2000, pp 86-94.

Jefferson JW: Lithium. In Aronson JK (ed), Side Effects of Drugs, Annual 23, Elsevier Science B.V., Amsterdam/New York, 2000, pp 23-33.

Greist JH and Jefferson JW: Obsessive-Compulsive Disorder. In Gabbard GO (ed.), Treatments of Psychiatric Disorders - Third Edition, Volume 2, American Psychiatric Press, Inc., Washington, D.C., 2001, pp 1515-1537.

Jefferson JW: Lithium. In Aronson JK (ed), Side Effects of Drugs, Annual 24, Elsevier Science B.V., Amsterdam/New York, 2001, pp 22-31.

Greist JH, Jefferson JW: Anxiety Disorders. In Beers MH, Fletcher AJ, Jones TV, Porter R, Berkwits M, Kaplan JL (eds.), The Merck Manual of Medical Information, Second Home Edition, Merck Research Laboratories, Whitehouse Station, NJ, 2003, pp 605-613

Jefferson JW: Lithium. In Aronson JK (ed), Side Effects of Drugs, Annual 26. Elsevier Science B.V., Amsterdam/NewYork, 2003, pp 19-29

Jefferson JW: Lithium. In Aronson JK (ed), Side Effects of Drugs, Annual 27. Elsevier Science B.V., Amsterdam/NewYork, 2004, pp 19-28

Jefferson JW and Greist JH: Lithium in psychiatric therapy. In Adelman G and Smith BH (eds.), Encyclopedia of Neuroscience, 3 rd enlarged and revised edition (CD ROM). Elsevier Science B.V., Amsterdam, The Netherlands, 2004

Jefferson JW and Greist JH: Lithium. In Sadock BJ and Sadock VA (eds.), Comprehensive Textbook of Psychiatry/VIII, vol. 2, Lippincott Williams & Wilkins, Philadelphia, PA, 2005, pp 2839-2851

Jefferson JW and Greist JH: Lithium. In Sadock BJ and Sadock VA (eds.), Comprehensive Textbook of Psychiatry/VIII, vol. 2, Lippincott Williams & Wilkins, Philadelphia, PA, 2005, pp 2839-2851

Jefferson JW: Raves, but no research. Clinical Psychiatry News 28(2):21, 2000 (letters).

Kobak KA, Kremer C, Greist JH, Jefferson JW, Burroughs D: Prospective naturalistic study of weight change associated with mirtazapine treatment for depression. Poster presentation at the National Institute of Mental Health, New Clinical Drug Evaluation Unit (NCDEU) 40th Annual Meeting, Boca Raton, Florida, May 30 - June 2, 2000.

Jefferson JW: It's a harmless herb (or is it?). Psychiatric Times 17(6):32-33, 2000.

Jefferson JW: Depression & anxiety. Aphorisms by Nascher. Geriatric Times 1(1):24-25, 2000.

Jefferson JW: Spectrum disorders: utilitarian concepts or utopian fantasies? Commentaries. In: M Maj, N Sartorius, A Okasha and J Zohar (eds.), Obsessive-Compulsive Disorder, John Wiley & Sons, Chichester, NY, 4:238-241, 2000.

Jefferson JW: Depression & anxiety. Old drugs for old folks. Geriatric Times 1(2):13-14, 2000.

Jefferson JW: Depression & anxiety. But I'm too old to be depressed (or anxious). Geriatric Times 1(3):31-32, 2000.

Jefferson JW: Lithium-associated clinical hypothyroidism. International Drug Therapy Newsletter 35(11):84-86, 2000.

Jefferson JW: Filling the void left by Freud - memoir-like reminiscences. In: The Triumph of Psychopharmacology and the Story of CINP, TA Ban, D Healy, E Shorter (eds), Animula Publishing House, Budapest, Hungary, 2000.

Jefferson JW: Depression & anxiety. My hippocampus is bigger than yours! Geriatric Times Nov/Dec:20-21, 2000.

Jefferson JW, Greist J: A double-blind comparison of citalopram and paroxetine in the treatment of patients with depression and anxiety. Poster presentation, 39th Annual Meeting of the American College of Neuropsychopharmacology, San Juan, Puerto Rico, December 10-14, 2000.

Feltner DE, Davidson JRT, Pollack MH, Stein MB, Futterer R, Jefferson JW, Lydiard RB, DuBoff E, Robinson P, Phelps M, Slomkowski M, Werth JL, Pande AC: A placebo-controlled, double-blind study of pregabalin treatment of social anxiety disorder: outcome and predictors of response. Poster presentation, 39th Annual Meeting of the American College of Neuropsychopharmacology, San Juan, Puerto Rico, December 10-14, 2000.

Jefferson JW: Depression & anxiety. So you thought you knew everything about lithium use in the elderly. Geriatric Times Jan/Feb:28, 2001.

Jefferson JW: Depression & anxiety. Hypotheticals. Geriatric Times March/April:2, 2001.

Jefferson JW: Clozapine and pulmonary embolus. American Journal of Psychiatry 158(3):499-500, 2001.

Jefferson JW, Greist JH: Depression and older people: recognizing hidden signs and taking steps toward recovery. An educational program sponsored by Pfizer, Inc. (booklet), 2001.

Jefferson JW: Depression & anxiety. Live happier, live longer? Geriatric Times 2(3):7, May/June 2001.

Jefferson JW: Mirtazapine-associated palinopsia. J Clin Psychiatry 62(5):373, 2001 (letter to editor).

Kobak KA, Greist JH, Jefferson JW, Katzelnick DJ, Mundt JC: New technologies to improve clinical trials. J Clin Psychopharmacology 21(3):255-6, 2001 (guest editorial).

Jefferson JW: Depression & anxiety. Alliterative euphony that kills. Geriatric Times 2(4):7, July/August 2001.

Jefferson JW: Tailoring SSRI treatment to the individual. In: Psychiatry Direct (Highlights of the 2000 U.S. Psychiatric & Mental Health Congress, San Diego, CA) Galen Press: Ghent, NY, 2001, pp 3-5.

Jefferson JW: Depression & anxiety. Who put the benzedrine in Mrs. Murphy's ovaltine? Geriatric Times 2(5):9-10, September/October 2001.

Jefferson JW: Lithium side effects and their management: an update. International Drug Therapy Newsletter 36(11):81-85, 2001.

Jefferson JW: Depression & anxiety. Growing old gracefully. Geriatric Times 2(6):6, November/December 2001.

Katzelnick DJ, Mundt JC, Greist JH, Jefferson JW: Remote assessment of dementia severity using interactive voice response. Poster presentation, 40th Annual Meeting of the American College of Neuropsychopharmacology, December 9-13, 2001.

Jefferson JW: Oxcarbazepine in bipolar disorder. Primary Care Companion J Clin Psychiatry 3(4):181, 2001.

Jefferson JW: Depression & anxiety. 'Q' stands for quality (of care). Geriatric Times 3(1):14, January/February 2002.

Jefferson JW: Depression & anxiety. Good grief, it's bad grief. Geriatric Times 3(2):6-7, March/April 2002.

Kobak KA, Greist JH, Jefferson JW, Katzelnick DJ: Validation of a computer administered version of the Liebowitz Social Anxiety Scale administered by telephone via interactive voice response (IVR). Poster presentation at the National Institute of Mental Health, New Clinical Drug Evaluation Unit (NCDEU) 42 nd Annual Meeting, Boca Raton, FL, June, 2002

Jefferson JW: SSRIs: Rosebushes with occasional thorns. Psychiatric Times 19(7):56, July 2002

Jefferson JW: Depression & anxiety. SSRIs: Rosebushes with occasional thorns. Geriatric Times 3(4):42-43, July/August 2002

Jefferson JW: Depression & anxiety. All natural, 100% effective, no side effects and guaranteed! Geriatric Times 3(5):8-9, 2002

Jefferson JW: Depression & anxiety. Departing from the putrid or tottering edifice. Geriatric Times 3(6):7, November/December, 2002

Jefferson JW: Invited comments on The Man with the Purple Nostrils. Acta Psychiatrica Scandinavica 106:466, 2002

Jefferson JW: Depression & anxiety. An ounce of prevention…? Geriatric Times 4(1):16, January/February, 2003

Jefferson JW: Benefits of low-dose lithium. Current Psychiatry 2(2):2, February, 2003 (letters)

Jefferson JW: Ripe and ripe, rot and rot. Geriatric Times 4(2):7-9, March/April, 2003

Jefferson JW: All about grapefruit. Newsweek Vol CXLI, March 31, 2003 (letters)

Jefferson JW: Depression & anxiety. Ferment your humours! Geriatric Times 4(3):18, May/June, 2003

Aga VM, Barklage NE, Jefferson JW: Linezolid, a monoamine oxidase inhibiting antibiotic, and antidepressants. J Clin Psychiatry 64(5):609-611, 2003 (letter to the editor)

Jefferson JW: Depression & anxiety. Blind as a bat and mad as a hatter. Geriatric Times 4(4):8, July/August, 2003

Jefferson JW: Depression & anxiety. Ferment your humours! Geriatric Times 4(3):18, May/June, 2003

Jefferson JW: Using lithium in bipolar disorder. Current Psychiatry 2(11):2, November, 2003 (letters)

Jefferson JW, Aga VM: Creatine kinase, not creatinine kinase. Journal of Clinical Psychopharmacology 23(6):668, 2003 (letter to editor)

Jefferson JW: All the data that are fit to print. Geriatric Times 5(1):8, January/February, 2004

Jefferson JW: Depression & anxiety. He punched, kicked and tried to kill his wife. Geriatric Times 5(2):31-32, March/April, 2004

Jefferson JW: Antipsychotic drugs: weight gain, diabetes and lipid abnormalities consensus development conference report. The Iris 22(8):14, April-May, 2004

Jefferson JW: He punched, kicked and tried to kill his wife. Psychiatric Times 21(5):69-72, 2004

Jefferson JW: From testicles to testosterone: help for the aging man? Geriatric Times 5(3):6-7, May/June, 2004

Jefferson JW: Comments on article by Harrigan et al: “A randomized evaluation of the effects of six antipsychotic agents on QTc, in the absence and presence of metabolic inhibition.” Journal of Clinical Psychopharmacology 24(4):456, 2004 (letter to the editor)

Jefferson JW: Depression & anxiety. Not expected? Then watch out for the unexpected!. Geriatric Times 5(4):16, July/August 2004

Jefferson JW: Invited comment on Suzuki K, Takei N, Iwata Y, et al.: Do olfactory reference syndrome and Jiko-shu-kyofu (a subtype of Taijin-kyofu) share a common entity? Acta Psychiatr Scand 109(2):155, 2004

Jefferson JW: Comments on article by Stein DJ: “Clinical manual of anxiety disorders.” American Journal of Psychiatry 162(1):200-201, 2005 (book forum)